Prestige Consumer Healthcare (PBH) Change in Intangibles (2014 - 2016)

Prestige Consumer Healthcare's (PBH) quarterly Change in Intangibles came in at $1.0 million in Q2 2016, little changed year-on-year from $1.0 million in Q3 2015, and little changed quarter-over-quarter from $1.0 million in Q4 2015.

Prestige Consumer Healthcare (PBH) Change in Intangibles (2014 - 2016) Analysis & Trends

Prestige Consumer Healthcare's Change in Intangibles history runs 3 years deep, the most recent figure standing at $1.0 million for Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -107.94 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.41 Bn 2.35 Bn 157.37 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2016 1.00 Mn
Jun 30, 2016 1.00 Mn
Dec 31, 2015 1.00 Mn
Dec 31, 2015 1.00 Mn
Sep 30, 2015 1.00 Mn
Sep 30, 2015 1.00 Mn
Jun 30, 2015 1.00 Mn
Jun 30, 2015 1.00 Mn
Dec 31, 2014 10.00 Mn
Dec 31, 2014 10.00 Mn